Suchergebnisse - "Lau, Christie J"

PubPharm (4)

1

Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent Resistance

enthalten in: Molecular cancer therapeutics | 2022

von Bahcall, M. | Paweletz, C. | Kuang, Y. | +15

2

Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade

enthalten in: The Journal of clinical investigation | 2021

von Sehgal, K. | Portell, A. | Ivanova, E. | +25

3

Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2019

von Rashidian, M. | LaFleur, M. | Verschoor, V. | +13

4

Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer

enthalten in: Oral oncology | 2019

von Hanna, G. | Lau, C. | Mahmood, U. | +5

CommentIn: Oral Oncol. 2019 Oct;97:149-150. - PMID 31375418

1
[1]